GLIOGENE is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With GLIOGENE, we may be able learn more about possible genes related to this disease -- and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease -- information that one day we hope will lead to improved treatment, as well as preventive strategies.

GLIOGENE is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study. Find out more...

MD ANDERSON NEWS

  • Improved chemotherapy administration reduces chance for medication errors
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=F0901BAD-7DE0-4047-BF03-3F07CD28E295 MD Anderson Cancer Center is the first hospital in the United States to implement a new technology that will greatly improve chemotherapy...
  • Melanoma Moon Shot update 2014
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=7E386C1A-AD1F-4336-8F7E-AA1ADB506254 Cases of melanoma and deaths from this form of skin cancer are on the rise.  MD Anderson is ideally suited to tackle this...
  • Chronic Lymphocytic Leukemia (CLL) Moon Shot update
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=AF8D6CD4-13BB-422D-9A38-3A6E2651962A Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one...